Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Hiromasa Matsubara"'
Autor:
Shuko Morita, Kensaku Yoshida, Yoichi Hamai, Eiji Oki, J. Hihara, Yuukou Kitagawa, Y. Emi, Chikara Kunisaki, T. Ueno, E. Otsuji, Hiromasa Matsubara, Yasuhiro Nakashima, Hideo Baba, Y. Maehara, Hiroya Takeuchi, K. Tomizuka, Hiroaki Nagano, Hiroshi Saeki, Yoshihiro Tanaka
Publikováno v:
ESMO Open
Background Oral mucositis (OM) is an unpleasant adverse event in patients receiving chemotherapy. A prospective feasibility study showed that elemental diet (ED), an oral supplement that does not require digestion, may prevent OM. Based on this, we e
Autor:
Hiroya Takeuchi, Eiji Oki, Hiroshi Saeki, Hiromasa Matsubara, Y. Maehara, Kensaku Yoshida, K. Tomizuka, Yoshihiro Tanaka, T. Ueno, Chikara Kunisaki, Yasuhiro Nakashima, Shuko Morita, E. Otsuji, Yoichi Hamai, Y. Emi, Yuukou Kitagawa, Hiroaki Nagano, Jun Hihara, Hideo Baba
Publikováno v:
Annals of Oncology. 31:S901-S902
Autor:
Takeshi Toyozumi, Isamu Hoshino, Gulbostan Yusup, Wei Qin, Xin Hu, Hiroshi Suito, Kentarou Murakami, Naoki Akanuma, Yasunori Akutsu, Yuka Isozaki, Tetsurou Maruyama, Hiromasa Matsubara, Nobufumi Sekino, Masahiko Takahashi
Publikováno v:
British Journal of Cancer
Background: FSCN1 and matrix metalloproteinase 14 (MMP14) are both invadopodia-related proteins. We herein elucidate the tumourigenicity of these proteins and identify novel therapeutic agents in esophageal squamous cell carcinoma (ESCC). Methods: FS
Autor:
Yasunori Akutsu, Yasuo Yoneyama, Norimasa Ikeda, Yuka Isozaki, Isamu Hoshino, Mikito Mori, Hiromasa Matsubara, Naoki Akanuma, Naoyuki Hanari, M Jitsukawa, Tetsurou Maruyama, Aki Komatsu, Nobuyoshi Takeshita
Publikováno v:
British Journal of Cancer
Background: Recent studies have demonstrated that microRNAs (miRNAs) are stably detectable in blood and can serve as useful biomarkers for cancer. Methods: We performed an miRNA array using serum samples obtained from oesophageal squamous cell carcin
Autor:
Akihiro Usui, K Murakam, Masahiko Takahashi, Xin Hu, Akiko Suganami, Yutaka Tamura, Hiromasa Matsubara, R Otsuta, Hiroshi Suito, Masayuki Kano, Yasunori Matsumoto, Naoyuki Hanari, Yasunori Akutsu, Wei Qin
Publikováno v:
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 30(7)
Esophageal squamous cell carcinoma is a highly aggressive neoplasm and the sixth leading cause of global cancer-related death; the 5-year survival rate for esophageal cancer is only about 20%-25% for all stages. Therefore, improving the therapeutic e
Autor:
H Saitou, Gaku Ohira, Akiko Kagaya, Kazuo Narushima, Hideaki Miyauchi, Kouichi Hayano, Y Mutou, Hiromasa Matsubara
Publikováno v:
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 19(1)
Aim This study aimed to assess the ability of preoperative axial computed tomography (CT) to predict surgical difficulty in bringing the ileal pouch to the level of the anus during restorative proctocolectomy (RPC). Method Patients who underwent RPC
Autor:
Takaki Hiwasa, Masayuki Kano, Satoru Yamada, Bahityar Rahmutulla, Kazuyuki Matsushita, Shuji Kubo, Hiromasa Matsubara, Hideaki Shimada, Fumio Nomura
Publikováno v:
Gene therapy. 23(1)
Combination therapy of carbon-ion beam with the far upstream element-binding protein (FBP)-interacting repressor, FIR, which interferes with DNA damage repair proteins, was proposed as an approach for esophageal cancer treatment with low side effects
Autor:
Toru Shiratori, Takenori Ochiai, Yoshio Gunji, Kiyohiko Shuto, Hideaki Shimada, Shinichi Miyazaki, Takashi Uno, Hiromasa Matsubara, Taito Aoki, Yoshihiro Nabeya, S Okazumi, Haruo Ito
Publikováno v:
Diseases of the Esophagus. 18:388-397
SUMMARY. Neoadjuvant chemoradiotherapy (CRT) was expected to improve surgical curability and prognosis for advanced esophageal cancer. However, the clinical efficacy of neoadjuvant CRT followed by esophagectomy with three-field lymphadenectomy (3FL)
Autor:
Toru Shiratori, S Okazumi, Yukimasa Miyazawa, Hiromasa Matsubara, Takenori Ochiai, Taito Aoki, Makoto Sugaya, Yoshihiro Nabeya, Hideaki Shimada
Publikováno v:
Diseases of the Esophagus. 17:159-163
In order to minimize the invasiveness of the operative procedure for thoracic esophageal cancer, several procedures have been introduced since January 1997. They included: (i) perioperative use of steroids; (ii) muscle-sparing thoracotomy without cos
Autor:
Hiromasa Matsubara, Yoshihiro Nabeya, S Okazumi, Haruyuki Hayashi, Yukimasa Miyazawa, Taito Aoki, T Shihratori, Sohei Kobayashi, Takenori Ochiai, Yoshio Gunji, Makoto Sugaya, Hideaki Shimada
Publikováno v:
Diseases of the Esophagus. 16:102-106
Immunosuppressive acidic protein (IAP) is a potent biological marker of immunological surveillance in patients with malignant tumors. The aim of this study was to analyze the clinicopathologic significance of IAP in patients with esophageal carcinoma